Created from the international operations of Altria in 2008, Philip Morris International sells cigarettes and reduced-risk products, including heat sticks, vapes, and oral nicotine offerings, primarily outside of the US... Show more
Philip Morris International shares have shown remarkable steadiness in recent weeks. After hovering near the $190 level in mid-August, the stock has moved in a tight band, finishing the most recent completed session near $191. The limited 30-day change of less than 1% underscores a market that is broadly comfortable with the company's fundamentals but awaiting fresh catalysts to justify a meaningful re-rating.
Within the consumer staples space, PM is often viewed as a hybrid of a defensive dividend payer and a growth-oriented transformation story. Its elevated yield relative to the broader market, combined with steady smoke-free expansion, has supported demand from income-focused and total-return investors alike. The stock's low volatility during the period reflects balanced sentiment rather than conviction-driven momentum.
Philip Morris International is one of the world's largest tobacco companies, selling combustible cigarettes, including the Marlboro brand outside the United States, across more than 175 markets. While traditional cigarettes still generate a substantial portion of revenue, the company has staked its future on a transition toward "smoke-free" alternatives.
Its flagship reduced-risk product, IQOS, is a heated tobacco system that has achieved widespread adoption in markets such as Japan and parts of Europe. Complementing IQOS, the company's ZYN nicotine pouches have become a fast-growing oral nicotine category leader. PM has set explicit long-term targets to shift a majority of net revenue to smoke-free products, a strategy that differentiates it from peers still heavily reliant on combustible volumes.
Investors follow PM closely for its scale, geographic diversification, strong cash generation, and disciplined capital returns through dividends and share repurchases.
The most recent 30-day stretch has been relatively quiet on company-specific news, which helps explain the stock's muted price action. Rather than a single catalyst, the shares have been shaped by a combination of steady operating trends and broader market forces.
Demand for ZYN nicotine pouches and continued momentum in IQOS volumes remain recurring themes supporting the company's growth narrative. At the same time, currency fluctuations in key emerging and developed markets continue to influence reported results, a persistent factor for a company with such extensive global exposure.
On the regulatory front, investors remain attentive to evolving rules around nicotine and smoke-free products in the United States and internationally. Any shift in how regulators treat oral nicotine or heated tobacco products has the potential to affect the pace of the company's transformation. Institutional positioning has remained broadly stable, consistent with the stock's low-volatility behavior over the period.
For traders looking to apply a more systematic approach, Tickeron's Trending AI Robots page offers a curated look at some of the most relevant AI-driven trading strategies available on the platform. Tickeron provides hundreds of AI trading bots that monitor thousands of tickers, but only the top-performing and most relevant bots are featured in this section, helping users cut through the noise. These bots vary widely in strategy, timeframe, and performance metrics, allowing traders to explore approaches that align with their own risk tolerance and objectives. Reviewing the curated list can be a practical way to see how algorithmic strategies are positioned across the market.
Looking ahead through 2026, several factors are likely to shape PM's trajectory. The pace of smoke-free volume growth—particularly for ZYN and IQOS—will remain a central focus, as investors track whether the company stays on course toward its smoke-free revenue targets. Pricing power in combustible categories will also matter, given its role in protecting margins and funding the transition.
Macroeconomic conditions, including foreign-exchange movements and consumer spending trends in key markets, represent ongoing variables. Regulatory clarity around reduced-risk and oral nicotine products could serve as either a tailwind or a headwind depending on how policies evolve. Finally, investors will watch the company's ability to sustain its dividend and capital-return program while investing in innovation and geographic expansion.
These drivers underscore why PM is viewed as a balanced story: a steady cash-generating business paired with a multi-year transformation that could redefine its long-term growth profile.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
PM moved below its 50-day moving average on September 18, 2026 date and that indicates a change from an upward trend to a downward trend. In 23 of 37 similar past instances, the stock price decreased further within the following month. The odds of a continued downward trend are 62%.
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 30 of 65 cases where PM's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 46%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where PM declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 46%.
The Momentum Indicator moved above the 0 level on September 11, 2026. You may want to consider a long position or call options on PM as a result. In 47 of 78 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 60%.
The Moving Average Convergence Divergence (MACD) for PM just turned positive on September 14, 2026. Looking at past instances where PM's MACD turned positive, the stock continued to rise in 29 of 48 cases over the following month. The odds of a continued upward trend are 60%.
The 10-day moving average for PM crossed bullishly above the 50-day moving average on September 17, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 8 of 14 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 57%.
Following a +2.68% 3-day Advance, the price is estimated to grow further. Considering data from situations where PM advanced for three days, in 226 of 384 cases, the price rose further within the following month. The odds of a continued upward trend are 59%.
PM may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Tickeron SMR rating for this company is 3 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 9 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 68, placing this stock better than average.
The Tickeron Valuation Rating of 20 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (-14.387) is normal, around the industry mean (16.593). P/E Ratio (25.897) is within average values for comparable stocks, (20.104). Projected Growth (PEG Ratio) (2.265) is also within normal values, averaging (3.706). Dividend Yield (0.031) settles around the average of (0.036) among similar stocks. PM's P/S Ratio (7.022) is slightly higher than the industry average of (2.780).
The Tickeron PE Growth Rating for this company is 31 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 45 (best 1 - 100 worst), indicating steady price growth. PM’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a manufacturer of cigarettes and other tobacco products
Industry Tobacco